However, Kaplan-Meier analysis of both the GSE10846 and GSE181063 datasets showed that high CD70 expression was associated with poor prognosis in DLBCL patients treated with chemotherapy. The gene discussed is CD70; the disease is diffuse large B-cell lymphoma.